NY-ESO-1-Specific T Cell Lines Now Available for Cancer Immunotherapy Research

After launching our first tumor-specific T cell line (anti-leukemia / WT-1 T cells) in November, we now have another exciting tumor-specific T cell line in our catalog: Anti-NY-ESO-1 T Cells! Applications for NY-ESO-1 Immunotherapies The NY-ESO-1 (New York Esophageal Squamous Cell Carcinoma 1) antigen is restricted to germ and placental cells, with re-expression in tumor…